| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 24, 2022 | SONX Sonendo, Inc. | Bergheim Bjarne | President And CEO | Buy | 5,000 | $2.67 | $13,363.00 | +0.6% | - | - | |
| May 24, 2022 | EKSO Ekso Bionics Holdings, Inc. | Sherman Steven72 | CEO &Chairman | Sell | 6,597 | $1.76 | $11,604.78 | -1.0% | +27.8% | -17.0% | |
| May 24, 2022 | CVRX Cvrx, Inc. | Nielsen Kirk G.82 | Director | Buy | 8,070 | $5.05 | $40,751.89 | +0.5% | +54.0% | +153.8% | |
| May 24, 2022 | DXCM Dexcom Inc | Pacelli Steven Robert57 | EVP Managing Director Dexcom V | Sell | 250 | $296.33 | $74,082.50 | -0.7% | +17.0% | +62.1% | |
| May 24, 2022 | IART Integra Lifesciences Holdings Corp | Evoli Lisa76 | Executive Vice President &CHRO | Sell | 250 | $59.85 | $14,962.53 | -1.2% | -11.8% | -34.9% | |
| May 24, 2022 | EW Edwards Lifesciences Corp | Zovighian Bernard J55 | Cvp, Tmtt | Sell | 4,809 | $95.52 | $459,355.68 | -10.8% | +1.4% | -11.3% | |
| May 24, 2022 | STXS Stereotaxis, Inc. | Isaac Paul J78 | Director, See Remarks | Buy | 14,292 | $1.82 | $25,983.60 | +0.3% | +26.3% | +17.9% | |
| May 24, 2022 | AHCO Adapthealth Corp. | Skyknight Capital Fund Ii, L.P.53 | Director | Buy | 209,300 | $17.31 | $3,622,327.59 | +2.5% | +19.5% | -36.9% | |
| May 24, 2022 | TELA Tela Bio, Inc. | Ew Healthcare Partners Fund 2, L.P.57 | See Footnote 2 | Buy | 15,000 | $8.17 | $122,550.00 | +0.1% | +23.8% | +60.2% | |
| May 24, 2022 | NMTC Neuroone Medical Technologies Corp | McClurg Ronald W.74 | Chief Financial Officer | Buy | 28,000 | $0.90 | $25,215.05 | +58.9% | +63.5% | +7.7% | |
| May 23, 2022 | CTSO Cytosorbents Corp | Capponi Vincent52 | President And COO | Buy | 5,000 | $2.03 | $10,164.24 | +0.4% | -5.5% | +52.0% | |
| May 23, 2022 | SONX Sonendo, Inc. | Bergheim Bjarne | President And CEO | Buy | 13,000 | $2.70 | $35,102.60 | +1.5% | - | - | |
| May 23, 2022 | AVTR Avantor, Inc. | Vanderhaegen Frederic65 | EVP, Americas &Europe | Sell | 39,000 | $31.61 | $1,232,790.00 | -23.5% | -17.0% | -33.8% | |
| May 23, 2022 | SONX Sonendo, Inc. | Smith Michael John | Chief Commercial Officer | Buy | 7,769 | $2.70 | $20,998.05 | +2.3% | - | - | |
| May 23, 2022 | CVRX Cvrx, Inc. | Nielsen Kirk G.82 | Director | Buy | 28,795 | $5.04 | $145,041.50 | +0.6% | +58.5% | +159.7% | |
| May 20, 2022 | VERO Venus Concept Inc. | Serafino Domenic | Chief Executive Officer | Buy | 65,000 | $0.75 | $48,750.00 | +7.5% | -43.7% | -78.2% | |
| May 20, 2022 | AVTR Avantor, Inc. | Brophy Gerard75 | EVP, Biopharma Production | Sell | 19,603 | $31.27 | $612,985.81 | -16.8% | -13.2% | -32.9% | |
| May 20, 2022 | STSS Sharps Technology Inc. | Hayes Robert Michael | Chief Executive Officer | Buy | 5,000 | $1.20 | $6,010.00 | +11.4% | +13.1% | -22.9% | |
| May 20, 2022 | IRIX Iridex Corp | Devi Nandini | Director | Buy | 2,000 | $3.10 | $6,199.80 | +23.8% | -12.3% | -24.2% | |
| May 20, 2022 | STXS Stereotaxis, Inc. | Isaac Paul J78 | Director, See Remarks | Buy | 43,263 | $1.80 | $77,725.17 | +0.9% | +36.9% | +25.7% | |
| May 20, 2022 | STIM Neuronetics, Inc. | Cannell Capital LLC69 | 10% Owner | Buy | 63,913 | $2.35 | $150,146.81 | +0.6% | +75.8% | +12.9% | |
| May 20, 2022 | ATEC Alphatec Holdings, Inc. | Miles Patrick53 | CEO | Sell | 300,000 | $8.13 | $2,438,000.00 | -1.7% | +12.8% | +95.4% | |
| May 20, 2022 | STAA Staar Surgical Co | Mason Caren L61 | President &CEO | Sell | 105,000 | $57.48 | $6,035,050.00 | -29.5% | +68.5% | +6.1% | |
| May 19, 2022 | HAE Haemonetics Corp | Llorens Josep59 | EVP, Global Manufacturing | Sell | 1,418 | $59.10 | $83,803.80 | -7.6% | +26.2% | +39.8% | |
| May 19, 2022 | HAE Haemonetics Corp | Simon, Christopher | President &CEO | Sell | 2,496 | $59.10 | $147,513.60 | -1.1% | +26.2% | +39.8% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.